VAERS Explorer
Back to explore

Report #2864526

Received Oct 9, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
52 yrs
State
OH
Recovered
Unknown
Vaccinated
Jun 25, 2025
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
DTAPDTAP (NO BRAND NAME)UNKNOWN MANUFACTURERUNK—OT

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

temperature excursion of vaccines due to refrigerator, Wi-Fi data loggers were not activated, and the USB data loggers for total hours 92.25 hours were not engaged with no adverse event; Initial information received on 24-Sep-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to the master case 2025SA202579. This case involves a 52 years old and unknown gender patient who administered to Diphtheria, Tetanus And Acellular Pertussis Vaccine which had temperature excursion due to refrigerator, Wi-Fi data loggers were not activated, and the USB data loggers for total hours 92.25 hours were not engaged with no adverse event The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 25-Jun-2025, the patient received an unknown dose of suspect Diphtheria, Tetanus And Acellular Pertussis Vaccine produced by unknown manufacturer (lot number, expiry date , formulation and strength not reported) via intramuscular route in unknown administration site for prophylactic vaccination (immunization) and temperature excursion of vaccines due to refrigerator, Wi-Fi data loggers were not activated, and the USB data loggers for total hours 92.25 hours were not engaged with no adverse event (product storage error). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: US-SA-2025SA202579: